Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 17
184
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

Anxiolytic-like effect of chrysophanol from Senna cana stem in adult zebrafish (Danio rerio)

, , &
Pages 4420-4424 | Received 26 Jan 2021, Accepted 06 Sep 2021, Published online: 22 Sep 2021
 

Abstract

The aim of this study was to evaluate the anxiolytic-like effect of chrysophanol (CHRY), isolated from hexane extract of Senna cana stem and its possible mechanism of action. CHRY was obtained through chromatographic treatments and its identity was confirmed by uni and bidimensional RMN1H and RMN13C. Adult zebrafish (n = 6/group) were treated (with CHRY (4.0 or 12.0 or 40.0 mg/Kg; 20 µL; intraperitoneally) and submitted to acute toxicity and open field tests. Subsequently, other groups (n = 6/each) received CHRY for the analysis of its effect on the Light & Dark Test. The participation of the GABAergic system was also assessed using the diazepam (GABAA receptor agonist) and flumazenil (GABAA receptor antagonist). CHRY was considered non-toxic, it did not reduce the locomotor activity, and showed an anxiolytic-like effect. This effect was reduced by pre-treatment with flumazenil. The results suggest that CHRY is an anxiolytic-like agent mediated via the GABAergic system.

Graphical Abstract

Acknowledgments

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The authors are extremely grateful to INCT BioNat (CNPq 465637/2014-0/FAPESP 2014/50926-0) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for all the financial support provided in the conduct of this research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.